Cantor Fitzgerald Reiterates Overweight on Johnson & Johnson, Maintains $215 Price Target
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Louise Chen has reiterated an Overweight rating on Johnson & Johnson (NYSE:JNJ) with a maintained price target of $215.
November 17, 2023 | 7:39 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cantor Fitzgerald analyst reaffirms Overweight rating on JNJ with a $215 price target, indicating a positive outlook on the stock.
The reiteration of an Overweight rating by a reputable analyst suggests a positive sentiment towards JNJ's stock performance. The maintained price target of $215 implies a potential upside from the current trading price, which could influence investor confidence and drive short-term price movement in a positive direction.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100